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Choledochal malformations (CMs) may be charac-
terised by inherent dilatation of the biliary tree without 
evidence of mechanical obstruction. Dilatation varies 
from florid and cystic to subtle and fusiform, and was 
first recognised during postmortem dissection by the 
German anatomist Abraham Vater, who reported his findings in his 
1723 thesis.[1] The objective of this article is to offer a clinically orien-
tated review and identify and discuss areas of controversy in detail.
Epidemiology
CMs can present at any point in the life cycle from an antenatal scan to 
the postmortem table, which makes the true incidence hard to define. 
If biliary atresia is used as a guide for a condition where the incidence 
is known (1 in 17 000) and the ratio of the two conditions presenting in 
infancy is taken from a specialist hepatobiliary unit in the UK, then an 
approximate figure of about 1 in 100 000 live births may be suggested. 
However, the incidence is much higher in Asian populations, and a female 
predominance of around 4:1 is consistently found in most series.[2-4]
There is no obvious hereditary element in most CMs, though a 
recent review identified 10 pairs of familial occurrence (siblings and 
offspring) in the literature.[5] Conversely, six pairs of monozygotic 
twins have been described in which a distinct CM appeared in only 
one pair. Aside from Caroli’s syndrome (see below), the condition 
is usually isolated. Fusiform biliary dilatation occasionally follows 
the repair of duodenal atresia, although proving this as an acquired 
aetiology is often difficult. 
Classification of choledochal 
malformations
One early point of controversy is what to call this entity (International 
Classification of Diseases, 9th revision, clinical modification (ICD-9-CM) 
diagnosis code 751.69). The older term, choledochal cyst, describes a 
predominantly spherical or globular biliary dilatation, and is actually 
only one type of CM. Modern authors have generally adopted a less 
prescriptive phrase, for example congenital CM (or dilatation).
The original classification was based upon a literature review 
by Alonso-Lej et al.[6] of 94 cases published up until the 1950s and 
included:
• Type 1: the classic cystic dilatation of the common bile duct
• Type 2: diverticulum from the common bile duct
• Type 3: localised dilatation of the distal common bile duct within 
the wall of duodenum – the choledochocele.
The Japanese authors Todani et al. developed their own classification 
during the 1970s and 1980s, defining three variants of type 1, two 
variants of type 4 (A & B) and adding isolated intrahepatic dilatation 
as type 5.[7] The classification is complex and many authors continue 
to misquote the original, especially confusing cystic and fusiform. 
The King’s College Hospital classification (Fig. 1) simplifies the Todani 
classification into types 1C and 1F (depending on the pre domi nant 
appearance as cystic or fusiform) and limits type 4 to the combination of 
intra- and extrahepatic dilatation. This classification has been the basis 
of our attempts to define pathophysiological characteristics to each type. 
Other workers have emulated this simpler approach.
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Fig. 1. King’s College Hospital classication of congenital CM. (CM = chole-
dochal malformation.)
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Type 4 CM is found in about 20% of large surgical series of CM and 
it is arguable whether this is simply the natural history of untreated 
types 1C and 1F. Some authors have distinguished cystic intrahepatic 
dilatation from a more fusiform intrahepatic dilatation, implying that 
the latter diminishes considerably following effective surgery. Our 
own follow-up study certainly demonstrated considerable resolution 
in intrahepatic duct dilatation in the first year post surgery.[8] 
Whether the choledochocele (type 3 CM) should be included at 
all in any classification was the subject of a recent North American 
series.[9] The authors argued that there were so many significant 
differences when compared with types 1, 2 and 4, particularly age 
at presentation (invariably as an adult) and gender (predominantly 
male) that it barely merited the term ‘congenital’. Certainly, the 
distinction between this and a long-standing dilated common 
channel, coupled with a degree of ampullary stenosis, is difficult. 
Isolated type 5 intrahepatic dilatation does occur and is distinct 
from what we recognise as Caroli’s syndrome. This latter entity 
struggles to fit into any classification of CM because it is so distinctly 
different. There is an obvious genetic abnormality, leading to a 
fundamental probable basement membrane defect in small bile ducts. 
The syndrome is associated with similar fundamental pathology 
affecting the kidney, manifesting as renal cystic disease or renal 
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Fig. 2. Choledochal pressure in relation to type of CM (n = 47) (A); choledochal 
pressure in relation to ELMS (n = 47) (B); and bile amylase concentration in 
relation to ELMS (n = 73) (C). Overall P = 0.002 (Kruskal-Wallis ANOVA). 
Figures reproduced with permission from Turoski et al.[13] (CM = choledochal 
malformation; ELMS = epithelial lining mural score.)
A
B
Fig. 3. A and B. Type 4 CM: Two-year-old boy presenting with recurrent 
jaundice.  ere is fusiform extra- and intrahepatic dilatation on magnetic 
resonance cholangiopancreatogram (A); at surgery the cholangiogram also 
shows a dilated common channel, partially obstructed by debris (white 
arrows) (B) with obvious re ux into the pancreatic duct (black arrows). 
 e bile amylase level in this case was 20  000 IU/L. (CM = choledochal 
malformation.)
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fibrosis. Furthermore, there is often associated parenchymal liver 
fibrosis in the absence of any particular bile duct obstruction. 
There is no doubt that part of the CM complex (at least in types 
1C, 1F and 4) is a degree of pancreaticobiliary malunion or ‘long’ 
common channel, with the junction lying outside of the wall of the 
duodenum (and therefore not under sphincteric control). Whether it 
is simply a reflection of disordered bile duct development during fetal 
life, and hence incidental, or is actually aetiological, as the Babbitt 
hypothesis implies (see below), remains to be argued. 
Aetiology
Two hypotheses have been put forward to explain the appearance and 
configuration of the common types of CM. The most fashionable has 
been the so-called Babbitt hypothesis,[10] which suggests that there is 
reflux of activated pancreatic enzymes via the common channel into 
the biliary tract. Donald Babbitt was an American radiologist who 
first observed this during cholangiography. The hypothesis suggests 
that this results in enzymatic damage to the local biliary epithelium 
and weakening of the bile duct wall, leading to dilatation and loss of 
bile duct structural integrity. An older hypothesis posits that there 
is a narrow stenotic portion of common bile duct, proximal to the 
common channel, that generates high intraductal pressures upstream. 
Prolonged exposure to elevated ductal pressure dilates the proximal 
lumen, similar to the dilatation seen in the bowel in congenital bowel 
atresia. Ligation of the duct in fetal lambs by the South African Lewis 
Spitz certainly produced cystic change in the delivered animals.[11]
We sought to disentangle these competing hypotheses in a series of 
reports based on clinical observations at the time of the laparotomy. 
Initially, we identified an inverse relationship between bile amylase 
(a surrogate of pancreatic juice reflux) and measured choledochal 
pressure.[12] We also determined that there was a stepwise increase in 
pressures observed from type 1F through type 1C to type 4 (Fig. 2A), 
accompanied by a reduction in bile amylases.[13] We then related these 
variables to a semiquantitive histological score, reflecting the damage 
done to the biliary epithelium, and showed that the most abnormal 
histology was in bile ducts with the highest pressures (and therefore 
the lowest amylase levels)(Fig. 2B and 2C).[13] These observations in 
clinical practice seemed to negate the central aetiological mechanism 
underlying the Babbitt hypothesis.
Clinical features 
The classic presentation with abdominal pain, jaundice and a mass 
in the right upper quadrant is in fact rarely seen in large paediatric 
series.[3] Infants tend to present with obstructive jaundice, and in later 
childhood and adult life, patients present with recurrent abdominal 
pain, with or without features of acute pancreatitis (Fig. 3).[2,3] Certainly, 
recurrent pancreatitis should be seriously considered as a cause for 
recurrent abdominal pain in childhood and actively excluded by the 
measurement of serum amylase or lipase. A value of >3 times the 
upper normal limit, in association with typical abdominal pain and/
or features of pancreatitis on cross-sectional imaging (the Atlanta 
criteria), confirms the diagnosis. Once a diagnosis of pancreatitis has 
been made, imaging (if not already completed) should at minimum 
consist of ultrasonography with a low threshold and continue on 
to a magnetic resonance cholangiopancreatogram and, if necessary, 
an endoscopic retrograde cholangiopancreatogram. Historically, 
untreated choledochal cysts caused cirrhosis and death in many 
instances (mortality rates approached 100% in the 1940s). Prompt 
surgical resection after diagnosis has rendered this scenario rare in 
recent times. 
Surgical intervention
Early attempts at surgical treatment of choledochal cysts usually 
involved internal drainage to adjacent intestinal loops or to the 
duodenum. This approach, leaving the cyst intact, persisted until 
at least the 1970s.[2] The Chicago surgeon G McWhorter is credited 
with the first successful resection and hepaticoduodenostomy (HD) 
in 1924.[14] 
Surgery is the only effective treatment for CMs, although the 
timing can be negotiated. With antenatal detection possible, some 
obvious type 1C CMs are picked up in the presymptom phase 
(Fig. 4). Some surgeons advocate immediate surgery during the 
neonatal period to forestall the development of silent hepatic fibrosis. 
However, deferment to about 3  -  6 months of age seems more 
pragmatic as liver biochemistry demonstrably returns to normal after 
the early neonatal period. 
A
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Fig. 4. A and B. Type 1C CM:  ree-month-old girl with a cyst detected 
antenatally at 18 weeks’ gestation. Subsequent imaging with magnetic 
resonance cholangiopancreatogram showed typical type 1C CM (A); early 
jaundice disappeared completely but intraoperative cholangiography 
(B) showed no onward passage of contrast, a high choledochal pressure 
(10  mmHg) and no evidence at all of bile amylase. (CM = choledochal 
malformation.)
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Farello et al.[15] first described the laparoscopic resection of a chole-
dochal cyst in a 6-year-old child in 1995. Since then, increasing 
numbers of specialist centres worldwide have adopted this challenging 
approach using minimally invasive techniques. In comparison with 
open surgery, operative times are longer and, certainly in early series, 
there was a higher incidence of complications such as anastomotic 
leaks without any real decrease in hospital stay (at least in children). 
More recently, huge single-institution series of more than 200 cases 
have been published from Bejing and Hanoi with much lower 
complication rates. This alludes to the increased centralisation of 
expertise in those countries and the effect of high-volume surgery.[4]
Minimally invasive resection is an advanced technique requiring 
considerable dexterity. Other techniques have been used to try to 
improve the quality of the biliary anastomosis – the Achilles heel of 
the entire operation. Thus, robot-assisted surgery has been reported 
to facilitate manual techniques, although the results from small 
series show a long learning curve and considerable complications.[16] 
Robots are a prohibitively expensive technology for many healthcare 
systems, and surgeons in large Asian series do not seem to require 
them. Extracorporeal jejunojeunostomy through a widened umbilical 
incision may also reduce operating times. Even single-incision 
surgery is possible, though apart from marginal improvement in 
cosmesis, there are no other advantages. 
What has been the most controversial recent technical development 
is a swing back to HD as the reconstruction device. Although the 
long (40 - 50 cm) Roux loop and hepaticojejunostomy have been the 
mainstay of biliary reconstructive surgery for approximately the past 
50 years, it is difficult to do laparoscopically. An easier alternative 
is a simple HD. The transected hepatic duct and the mobilised 
first and second parts of the duodenum can be in close proximity. 
However, there is a fundamental problem with this technique, which 
manifested some years ago by surgeons who once preferred it as an 
open technique. 
Todani was a long-time advocate of HD, but also showed that 
about 10  -  20% of patients have symptomatic bile gastritis due to 
reflux across the pylorus and a 10% incidence of cholangitis due to 
reflux of non-sterile duodenal content into the biliary tree, which 
is often dilated. The final straw, from his perspective, was the 
development of a bile duct carcinoma at the portal hilum 19 years 
after primary cyst excision and HD performed on a 13-month-old 
patient. He then switched to hepaticojejunostomy for the rest of his 
career. Other authors in comparative trials have also come to the same 
conclusion. [17] Therefore, what is wrong with hepaticojejunostomy-
en-Roux? In our opinion, not much. It is non-physiological and 
takes a significant amount of absorptive jejunal surface area out of 
the intestinal sequence. Furthermore, there is constant bile drainage 
and no intermixing with pancreatic juice until the jejunal union. In 
a recent study of growth indices in our series of over 100 operated 
CMs, we found a significant incidence of failure to thrive and lower 
preoperative weights when compared with the age-corrected normal 
population. However, after surgery, all patients showed satisfactory 
catch-up weight gain at 1 year and sustained weight gain thereafter 
(unpublished observations). 
Malignant transformation and  
cancer risk
The long-term risk of malignant transformation in CM has 
been well described and is evident in many published series of 
adults with CM. This risk is probably due to ongoing chronic 
inflammation in the epithelium over many years, exacerbated 
by episodic cholangitis and stone formation. The youngest case 
appears to be an 11-year-old boy, reported by Tanaka et al.[18] in 
2006, who developed adenocarcinoma in a type 4 CM. Tanaka et al. 
also identifed ten more cases from the literature in patients aged 
<20 years, the majority also arising in long-standing type 4 CMs. 
What is not known with any certainty is the risk of carcinoma in 
the residual biliary epithelium in the liver or in the head of the 
pancreas following CM resection in the modern world. We simply 
have not been doing this kind of surgery long enough to know what 
happens years later during adulthood. At the very least, however, 
it should be axiomatic that treated children and adolescents are 
followed up – ideally by serial ultrasonography. Persistence of 
intrahepatic dilatation and the development of stones and debris 
should encourage more invasive investigation. 
Discussion of CM and cancer inevitably overlaps with the problems 
of what to do in patients with an isolated common channel (usually 
defined as >6  mm long and also referred to in the literature as 
pancreaticobiliary maljunction). Almost paradoxically, there seems 
to be a greater malignancy risk with common channels unassociated 
with CM. In one Japanese survey of hepatobiliary surgical practice, 
biliary cancer occurred in 22% of adult patients with biliary dilatation 
and 42% of those without biliary dilatation. Gallbladder cancer is the 
usual malignancy in the latter group.[19]
Conclusion 
Treatment outcome in CM has improved dramatically over the last 60 
years, led by earlier diagnosis, prompt surgical excision and effective 
biliary drainage. There are still unresolved issues surrounding the 
nature and style of surgical reconstruction, but long-term success 
with normal liver function is unequivocal. 
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